Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alzheimer Blood Biomarkers”

67 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 67 results

Not applicableWithdrawnNCT06856681
What this trial is testing

Clinical Utility of Early vs. Late Blood Biomarker Testing for Alzheimer's Disease

Who this might be right for
Alzheimers Disease
C2N Diagnostics
Not applicableStudy completedNCT07069244
What this trial is testing

Investigation of the Relationship Between Periodontitis and Alzheimer's Disease in Terms of Blood Parameters

Who this might be right for
Periodontal DiseasePeriodontitisPeriodontal Inflammation+3 more
Uskudar University 100
Not applicableNot Yet RecruitingNCT06825663
What this trial is testing

Marker of Brain Insulin Resistance in AD Prognosis

Who this might be right for
Prognosis Biomarker of ADMild Cognitive ImpairmentBrain Insuline Resistance
Central Hospital, Nancy, France 122
Testing effectiveness (Phase 2)Ended earlyNCT03702816
What this trial is testing

The Relationship Between Neuropsychological Testing and MRI, PET and COBRE - Project 1: AIM 2 (GE-180)

Who this might be right for
Alzheimer DiseaseParkinson DiseaseInflammation
Aaron Ritter, MD 24
Early research (Phase 1)Study completedNCT00757939
What this trial is testing

Assess Regional Cerebral Blood Flow as an Alzheimer's Disease Biomarker Compared to Positron Emission Tomography in Patients With Mild-to-Moderate Alzheimer's Disease and Cognitively Normal Elderly Subjects (Study MK-0000-068)(COMPLETED)

Who this might be right for
Alzheimer's Disease
Merck Sharp & Dohme LLC 40
Large-scale testing (Phase 3)Study completedNCT02719327
What this trial is testing

Brain Amyloid and Vascular Effects of Eicosapentaenoic Acid

Who this might be right for
Alzheimer's Disease
VA Office of Research and Development 131
Not applicableLooking for participantsNCT06339190
What this trial is testing

Neurofilament Light Chain And Voice Acoustic Analyses In Dementia Diagnosis

Who this might be right for
Neurodegenerative DiseasesDementia
Monash University 1,000
Not applicableActive Not RecruitingNCT06754254
What this trial is testing

Blood Biomarkers from Internal Jugular Vein for the Diagnosis of Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University 300
Not applicableNot Yet RecruitingNCT06304129
What this trial is testing

Diagnostic Performance of Plasma Biomarkers of Alzheimer's Disease Compared With CSF Markers

Who this might be right for
Alzheimer Blood Biomarkers
Central Hospital, Nancy, France 189
Not applicableEnrolling By InvitationNCT07238049
What this trial is testing

REAl World Dementia OUTcomes: Observational Study

Who this might be right for
Alzheimer Disease (AD)Mild Cognitive Impairment (MCI)Dementia
University of Oxford 3,165
Not applicableUnknownNCT03977025
What this trial is testing

Alzheimer Biomarkers on CSF of Elderly Patients Undergoing Surgery

Who this might be right for
Alzheimer Disease
University of Chile 30
Not applicableLooking for participantsNCT07153848
What this trial is testing

An Observational Study on Lecanemab Treatment for Early Alzheimer's Disease

Who this might be right for
Alzheimer Disease
First Affiliated Hospital of Zhejiang University 400
Not applicableLooking for participantsNCT06584357
What this trial is testing

Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia

Who this might be right for
Mild Cognitive ImpairmentAlzheimer's DiseaseAlzheimer's Disease, Early Onset+3 more
GAP Innovations, PBC 1,200
Not applicableLooking for participantsNCT07146412
What this trial is testing

Impact of a Multimodal Lifestyle Intervention on Dementia Risk Factors and Attitude Related to Dementia Risk: A Logistical Pilot Study

Who this might be right for
Cognitive ImpairmentAlzheimer Blood BiomarkersAlzheimer Disease (AD)+1 more
HudsonAlpha Institute for Biotechnology 200
Not applicableLooking for participantsNCT07435467
What this trial is testing

Blood Biomarkers for Alzheimer Disease and Neuro-injury to Estimate the Association With Cognitive/Functional Decline and Mortality in a Real-world Population of GERiatric Hospitalized Patients (BAD-GER)

Who this might be right for
Alzheimer DiseaseOld Age; Dementia
Istituto Nazionale di Ricovero e Cura per Anziani 400
Not applicableNot Yet RecruitingNCT07286812
What this trial is testing

Digital Technology Combined With Blood Marker Screening and Diagnosis for Community Populations Based on Classification Theory: an Integrated Study

Who this might be right for
Alzheimer Disease
First Hospital of China Medical University 1,000
Testing effectiveness (Phase 2)Looking for participantsNCT07392723
What this trial is testing

ALA-enriched Nutrition for Prevention of Cognitive Decline in APOE4 Older Adults

Who this might be right for
Cognitive DysfunctionAlzheimer DiseaseBlood-Brain Barrier+3 more
Michal Schnaider Beeri, Ph.D. 20
Not applicableLooking for participantsNCT06477484
What this trial is testing

Blood Biomarkers for Screening of Alzheimer's Disease

Who this might be right for
Alzheimer's DiseaseBlood Biomarkers
Peking University First Hospital 180
Not applicableStudy completedNCT05582941
What this trial is testing

Biomarkers of Cognitive Impairment in Blood Cells

Who this might be right for
Mild Cognitive Impairment Due to Alzheimer's DiseaseDementia Due to Alzheimer's Disease (Disorder)
University of the Balearic Islands 48
Not applicableNot Yet RecruitingNCT06756828
What this trial is testing

Effects of 3-Month Melatonin Treatment on Regional Cerebellar Structure and Blood Biomarkers in Alzheimer's Disease Spectrum

Who this might be right for
ElderlyAlzheimer DiseaseMelatonin+3 more
Saint Vincent's Hospital, Korea 40
Load More Results